中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2009年
1期
20-22
,共3页
费伦%楼健颖%林汉庭%吴丹
費倫%樓健穎%林漢庭%吳丹
비륜%루건영%림한정%오단
肝胰管壶腹%肿瘤复发,局部%导管消融术%超声疗法
肝胰管壺腹%腫瘤複髮,跼部%導管消融術%超聲療法
간이관호복%종류복발,국부%도관소융술%초성요법
Ampulla of Vater%Neoplasm recurrence,local%Catheter ablation%Ultrasonic therapy
目的 探讨壶腹周围癌术后局部复发的治疗方法.方法 回顾分析1997年1月至2007年5月23例壶腹周围癌术后复发病例的治疗,其中3例行再手术切除,5例剖腹探查术中行射频消融,10例行高强度聚焦超声热疗,5例行区域性动脉灌注化疗.结果 本组壶腹周围癌术后局部复发再手术切除率为13%.2例术后生存期分别为10个月和13个月,另1例术后至今6个月仍无瘤生存.20例通过射频消融、高强度聚焦超声热疗及区域性动脉灌注化疗后症状均有不同程度地缓解.结论 对于壶腹周围癌术后局部复发患者,再次手术切除有助于减轻症状,延长生存期;对不能手术者,可选择射频消融、高强度聚焦超声热疗和区域性动脉灌注化疗治疗.
目的 探討壺腹週圍癌術後跼部複髮的治療方法.方法 迴顧分析1997年1月至2007年5月23例壺腹週圍癌術後複髮病例的治療,其中3例行再手術切除,5例剖腹探查術中行射頻消融,10例行高彊度聚焦超聲熱療,5例行區域性動脈灌註化療.結果 本組壺腹週圍癌術後跼部複髮再手術切除率為13%.2例術後生存期分彆為10箇月和13箇月,另1例術後至今6箇月仍無瘤生存.20例通過射頻消融、高彊度聚焦超聲熱療及區域性動脈灌註化療後癥狀均有不同程度地緩解.結論 對于壺腹週圍癌術後跼部複髮患者,再次手術切除有助于減輕癥狀,延長生存期;對不能手術者,可選擇射頻消融、高彊度聚焦超聲熱療和區域性動脈灌註化療治療.
목적 탐토호복주위암술후국부복발적치료방법.방법 회고분석1997년1월지2007년5월23례호복주위암술후복발병례적치료,기중3례행재수술절제,5례부복탐사술중행사빈소융,10례행고강도취초초성열료,5례행구역성동맥관주화료.결과 본조호복주위암술후국부복발재수술절제솔위13%.2례술후생존기분별위10개월화13개월,령1례술후지금6개월잉무류생존.20례통과사빈소융、고강도취초초성열료급구역성동맥관주화료후증상균유불동정도지완해.결론 대우호복주위암술후국부복발환자,재차수술절제유조우감경증상,연장생존기;대불능수술자,가선택사빈소융、고강도취초초성열료화구역성동맥관주화료치료.
Objective To evaluate the treatment modalities for local recurrent periampullary carcinoma. Methods From January 1997 to May 2007, 23 patients with local recurrent periampullary carcinoma underwent different therapy. The recurrent tumor was resected through laparotomy in 3 cases and the unresectable tumors were treated with radiofrequency ablation(RFA) in 5 patients. In 10 patients and 5 patients respectively high intensity focused ultrasound ( HIFU ) and regional chemotherapy ( RC ) were performed. Results The resection rate for local recurrent periampullary carcinoma was 13% in this group, 2 patients have survived for 10 months and 13 months respectively after reoperation while one patient achieved tumor-free survival for six months so far. The symptoms were alleviated to some extent in 20 patients treated with RFA, HIFU or RC. Conclusions Resection of local recurrent periampullary carcinoma may benefit a longer survival time, and the improvement of the quality of life. RFA, HIFU and RC are the alternative modalities for patients with unresectable tumors.